PT96229B - Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico - Google Patents

Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico Download PDF

Info

Publication number
PT96229B
PT96229B PT96229A PT9622990A PT96229B PT 96229 B PT96229 B PT 96229B PT 96229 A PT96229 A PT 96229A PT 9622990 A PT9622990 A PT 9622990A PT 96229 B PT96229 B PT 96229B
Authority
PT
Portugal
Prior art keywords
weight
naproxen
binder
tablets
paste
Prior art date
Application number
PT96229A
Other languages
English (en)
Portuguese (pt)
Other versions
PT96229A (pt
Inventor
Roy Kuramoto
Zakauddin Tanwir Chowhan
Randal Owen Pendleton
Hafez Hafezzadeh
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of PT96229A publication Critical patent/PT96229A/pt
Publication of PT96229B publication Critical patent/PT96229B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96229A 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico PT96229B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (2)

Publication Number Publication Date
PT96229A PT96229A (pt) 1991-09-30
PT96229B true PT96229B (pt) 1998-06-30

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96229A PT96229B (pt) 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico

Country Status (16)

Country Link
EP (1) EP0436373B1 (de)
JP (1) JPH05320045A (de)
KR (1) KR910011241A (de)
AT (1) ATE110267T1 (de)
AU (1) AU640725B2 (de)
CA (1) CA2032956A1 (de)
DE (1) DE69011836T2 (de)
ES (1) ES2063296T3 (de)
FI (1) FI906372A7 (de)
HU (1) HUT59594A (de)
IE (1) IE904666A1 (de)
IL (1) IL96749A0 (de)
NO (1) NO905557L (de)
NZ (1) NZ236631A (de)
PT (1) PT96229B (de)
ZA (1) ZA9010353B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ251806A (en) * 1992-04-15 1996-01-26 Marion Merrell Dow Inc Making compressed tablets containing aminoguanidine or a salt thereof and a binder, by first spray-drying an aqueous solution to form a powder
AU5135898A (en) * 1996-12-03 1998-06-29 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
RU2191577C1 (ru) * 2001-04-19 2002-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая противовоспалительная композиция и способ ее получения
CN1325049C (zh) * 2001-07-30 2007-07-11 Dsmip资产有限公司 含有表没食子儿茶素没食子酸酯的组合物
EP1469833B1 (de) 2002-02-01 2021-05-19 Bend Research, Inc. Verfahren zur herstellung homogenisierter sprühgetrockneter fester amorpher wirkstoffdispersionen, das eine modifizierte vorrichtung zur sprühtrocknung verwendet
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
WO2017010487A1 (ja) * 2015-07-13 2017-01-19 協和発酵バイオ株式会社 アルギニンを高含有する錠剤
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
BR112022003419A2 (pt) * 2019-08-26 2022-05-24 Dsm Ip Assets Bv Forma de dosagem oral sólida compreendendo naproxeno e vitamina b12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
HU908395D0 (en) 1991-07-29
NO905557D0 (no) 1990-12-21
FI906372A0 (fi) 1990-12-21
IE904666A1 (en) 1991-07-17
PT96229A (pt) 1991-09-30
CA2032956A1 (en) 1991-06-23
ZA9010353B (en) 1992-08-26
ATE110267T1 (de) 1994-09-15
NO905557L (no) 1991-06-24
FI906372L (fi) 1991-06-23
IL96749A0 (en) 1991-09-16
DE69011836T2 (de) 1995-03-09
AU640725B2 (en) 1993-09-02
DE69011836D1 (de) 1994-09-29
KR910011241A (ko) 1991-08-07
EP0436373B1 (de) 1994-08-24
EP0436373A1 (de) 1991-07-10
AU6837590A (en) 1991-06-27
NZ236631A (en) 1993-03-26
FI906372A7 (fi) 1991-06-23
ES2063296T3 (es) 1995-01-01
JPH05320045A (ja) 1993-12-03
HUT59594A (en) 1992-06-29

Similar Documents

Publication Publication Date Title
JP3728321B2 (ja) 圧縮性を改良した医薬品賦形剤
PT96229B (pt) Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
EP1109536B1 (de) Neue feste dosisform enthaltend nanopartikelnaproxen
JP2021178871A (ja) エンザルタミドの製剤
US10493161B2 (en) Solution for spray drying comprising hypromellose acetate succinate and method for producing solid dispersion
KR101661256B1 (ko) 락토스 및 셀룰로스 주성분의 타정용 보조제
TW200302740A (en) Immediate release dosage forms containing solid drug dispersions
BRPI0714586A2 (pt) formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
ITMI991402A1 (it) Composti amorfi e relative composizioni farmaceutiche
BRPI0620185A2 (pt) formulaÇço farmacÊutica, tabletes, e, processo para a preparaÇço de uma formulaÇço farmacÊutica
MXPA02007076A (es) Preparacion de ingrediente activo de ibuprofeno.
JPH0819003B2 (ja) 有核顆粒およびその製造法
US5470580A (en) Directly-compressible naproxen or naproxen sodium compositions
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
EP1103258A1 (de) Feste zubereitungen die wenig lösliche nsaids enthalten
KR20110053956A (ko) 검 및 당 알콜을 포함하는 지속 방출 제제
US20030153623A1 (en) Solid preparation containing sparingly soluble NSAIDs
CN1274579A (zh) 生产含核黄素的颗粒的方法
JP2025162521A (ja) 非晶質固体分散体を含む複合物
JP4591742B2 (ja) ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法
WO2017209216A1 (ja) 難溶性薬物の微粒子を含有する医薬組成物の製造方法
WO2024030098A1 (en) A tablet of tolvaptan and at least one binder processed with spray granulation
EP4479057A1 (de) Tablette aus tolvaptan und mindestens einem bindemittel, das mit nassgranulation verarbeitet ist
WO2023158411A1 (en) A tablet of tolvaptan and at least one binder processed with wet granulation

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910506

FG3A Patent granted, date of granting

Effective date: 19980313

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930